a developer of non invasive epicutaneous diagnostics systems and immunotherapy for allergy diagnostics
Industry Biotechnology
A.I.dvisor tells us that DBVT and CRDF have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DBVT and CRDF's prices will move in lockstep.
Ticker / NAME | Correlation To DBVT | 1D Price Change % | ||
---|---|---|---|---|
DBVT | 100% | +7.39% | ||
CRDF - DBVT | 32% Poorly correlated | +4.19% | ||
SNPX - DBVT | 29% Poorly correlated | +0.49% | ||
GLSI - DBVT | 29% Poorly correlated | +6.82% | ||
ALT - DBVT | 26% Poorly correlated | +6.46% | ||
RXRX - DBVT | 25% Poorly correlated | +3.07% | ||
More |